Purchase Order 75N93023P00585
Award Date
5/9/23
Potential Completion Date
6/15/23
Potential Value
$15K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Bioreliance Corporation
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract valued at $15,434.00 to Bioreliance Corporation, a foreign-owned for-profit organization. The contract is for endotoxin and sterility testing services to support investigational new drug applications. Bioreliance Corporation, through its Life Sciences Services division doing business as Bioreliance...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order to Bioreliance Corporation's Life Sciences Services Division, doing business as Bioreliance Corp De, for $15,434.00 in endotoxin and sterility testing services. The contract, which has a completion date of June 12, 2024, is to provide isolator sterility testing, Limulus Amebocyte Lysate (LAL) testing for...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15,434.00 firm-fixed-price purchase order to Bioreliance Corporation, a foreign-owned for-profit organization, for endotoxin and sterility testing services. The contract has an ultimate completion date of September 8, 2025. Bioreliance, through its Life Sciences Services division, provides specialized microbiological examination, bioburden...
The Department of Health and Human Services National Institutes of Health (NIH) National Cancer Institute awarded a $80,848.00 Delivery Order contract to Bioreliance Corporation, a foreign-owned for-profit organization, for sterility testing services. The contract is for endotoxin, sterility, and general safety testing to support investigational new drug applications. Bioreliance has a history of providing these types of testing services to the NIH National Institute of Allergy and Infectious...
This federal contract was awarded to Bioreliance Corporation, a foreign-owned, for-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $6,065,128.00, is a definitive contract with a cost-plus-fixed-fee pricing type. Bioreliance, through its Life Sciences Services Division, will provide a range of specialized testing services to support investigational new drug...
This federal contract award, with ID HHSN272201600262P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioreliance Corporation, a foreign-owned, for-profit organization that specializes in providing critical testing services to the U.S. government. The $9,566.00 fixed-price contract is for endotoxin testing services, which are crucial for advancing health initiatives and drug development processes. Bioreliance, through its Life Sciences Services Division,...
Bioreliance Corporation, a foreign-owned for-profit organization, was awarded a $34,978 firm-fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) to provide endotoxin, sterility, and general safety testing services in support of investigational new drug (IND) applications for NIAID's Pfs230D1-CRM197 and Pfs230D1-EPA malaria vaccine products. The contract, which does not have a set-aside designation, runs through August 31, 2024. Bioreliance has...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization. The $88,338.85 firm fixed-price delivery order contract is for sterility testing services, including endotoxin, general safety, and microbiological examination testing to support investigational new drug applications. Bioreliance has a long history of providing these services to...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Firm Fixed Price delivery order contract to Bioreliance Corporation, a foreign-owned for-profit organization that primarily provides endotoxin, sterility, and general safety testing services through its Life Sciences Services division. The contract, valued at $36,008.23, is for the delivery of "STERILITY ASSAY, LINE ITEM 119 UNITS: EACH CATALOG#: 510120GMP.BSV"...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization that provides endotoxin, sterility, and general safety testing services through its Life Sciences Services division. The contract is for the delivery of Sterility Units, catalog number 510120GMP.BSV, with a firm fixed price of $35,018.20 and a completion date of June 30, 2013. No...